Combined therapy with rosuvastatin and ezetimibe on inflammatory state and pro-inflammatory cytokines in patients with coronary heart disease and metabolic syndrome

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Risk factors and prevention Diabetes and the Heart HFA Premium Access Heart Failure 2019

ESC 365 is supported by

ESC 365 is supported by